Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 11;16:107–117. doi: 10.2147/CIA.S269171

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 You et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

MiR-197-3p and KLF10 expression levels in osteogenic differentiation. (A) Levels of osteogenesis-related genes in primary osteoblasts including ALP, RUNX2, OCN, and OSX after 7 d of OM treatment. (B) Expression of miR-197-3p in primary osteoblasts 7 d after OM treatment. (C) Expression of KLF10 in primary osteoblasts 7 d after OM treatment. (D) Levels of osteogenesis-related genes in MC3T3-E1 cells include levels of OCN, RUNX2, ALP and OSX 7 d after OM treatment. (E) MiR-197-3p expression in MC3T3-E1 cells 7 d after OM treatment. (F) On the 7th day after OM treatment, the expression of KLF10 in MC3T3-E1 cells. N = 3. ** P <0.01.